Fundraising Fox
/Companies
Sign in

Sonovascular

Chapel Hill, US · Founded 2018 · North Carolina corporation · 3 known investors

Find your way into Sonovascular

Each arrow is one introduction. Sign up to fill in the first one.

169 people can intro you to Daniel

Ask Todd Berard to introduce you to Daniel Estay

You →Todd · together at Verathon →Daniel

Sign up to find every way you can get introduced to Sonovascular

  • Your email: who you already know at Sonovascular, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sonovascular team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.

BiotechHealthtechMedical Devices

Founders & leadership

Sonovascular was founded in 2018 by Daniel Estay.

DE
Daniel EstayFounderDaniel Estay is an Executive Officer and Director at Sonovascular, a cardiovascular medical device company developing interventional treatments for venous thromboembolism. He has built experience leading multidisciplinary teams in engineering, clinical, and regulatory functions for interventional device development.
WN
William N. StarlingNamed on SEC filing

Investors · 3

ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto

How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us

Wolfpack Investor Networklisted by Wolfpack Investor NetworkRaleigh · $250K – $5M

How we know: Wolfpack Investor Network's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 1 round · 2021

▶$2.2MraisedJan 2023 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William N. StarlingDirector
  • Daniel EstayExecutive Officer, Director
Offering amount
$2.2M
Amount sold
$2.2M
First sale
Dec 2021
Incorporated
Corporation, North Carolina, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

Innova VascularInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
NeuroVascNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Sonex HealthSonex Health develops ultrasound-guided medical devices for orthopedic conditions, including UltraGuideCTR, a device that enables carpal tunnel release to be performed in a clinic setting. The company targets physicians and healthcare providers seeking minimally invasive treatments with faster patient recovery.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
SonavexSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.

Companies working in the same space as Sonovascular.

Frequently asked questions

What does Sonovascular do?
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
Who founded Sonovascular?
Sonovascular was founded by Daniel Estay in 2018.
Who are Sonovascular's investors?
Sonovascular's investors include Band of Angels, ShangBay Capital LLC, Wolfpack Investor Network.
How much funding has Sonovascular raised?
Sonovascular has disclosed $2.2M raised across 1 round.
Where is Sonovascular headquartered?
Sonovascular is headquartered in Chapel Hill, US.